CVE-2025-3883

eCharge Hardy Barth cPH2 index.php Command Injection Remote Code Execution Vulnerability

Description

eCharge Hardy Barth cPH2 index.php Command Injection Remote Code Execution Vulnerability. This vulnerability allows network-adjacent attackers to execute arbitrary code on affected installations of eCharge Hardy Barth cPH2 charging stations. Authentication is not required to exploit this vulnerability. The specific flaw exists within the handling of GET parameters provided to the index.php endpoint. The issue results from the lack of proper validation of a user-supplied string before using it to execute a system call. An attacker can leverage this vulnerability to execute code in the context of the www-data user. Was ZDI-CAN-23115.

Category

8.8
CVSS
Severity: High
CVSS 3.0 •
EPSS 0.10%
Affected: eCharge Hardy Barth cPH2
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-3883?
CVE-2025-3883 has been scored as a high severity vulnerability.
How to fix CVE-2025-3883?
To fix CVE-2025-3883, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-3883 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-3883 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-3883?
CVE-2025-3883 affects eCharge Hardy Barth cPH2.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.